Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Bradley C, Martin"'
Autor:
Antonije Lazic, J. Mick Tilford, Bradley C. Martin, Mandana Rezaeiahari, Anthony Goudie, Ahmad Baghal, Melody Greer
Publikováno v:
American Journal of Medicine Open, Vol 12, Iss , Pp 100070- (2024)
Background: Studies examining racial and ethnic disparities in-hospital mortality for patients hospitalized with COVID-19 had mixed results. Findings from patients within academic medical centers (AMCs) are lacking, but important given the role of AM
Externí odkaz:
https://doaj.org/article/f0ecf02ee6a342e8b5b64b9f740d6c75
Autor:
Mahip Acharya, Kristin K. Zorn, Melinda E. Simonson, Milan Bimali, Gary W. Moore, Cheng Peng, Bradley C. Martin
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Early identification of hereditary cancer risk would save lives, but genetic testing (GT) has been inadequate. We assessed i) trends for hereditary breast and ovarian cancer (HBOC), Lynch syndrome, and other GT and ii) factors ass
Externí odkaz:
https://doaj.org/article/b31401a04b844426bd2b15a52657c66b
Autor:
Benjamin S. Teeter, Catherine R. Jensen, Jeremy L. Thomas, Bradley C. Martin, Pearl A. McElfish, Cynthia L. Mosley, Geoffrey M. Curran
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 2, Iss , Pp 100014- (2021)
Background: Human Papillomavirus (HPV) is the most common sexually transmitted disease in the United States (US), with 12 cancer causing strains. Vaccination rates in the southern US fall below the national average. Pharmacists provide an opportunity
Externí odkaz:
https://doaj.org/article/c159af6b41b443479a549eefded5061e
Autor:
Benjamin S. Teeter, Mary M. Thannisch, Bradley C. Martin, Nickolas D. Zaller, Duane Jones, Cynthia L. Mosley, Geoffrey M. Curran
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 2, Iss , Pp 100019- (2021)
Introduction: Fatal overdoses from opioids increased four-fold from 1999 to 2009, and they are now the leading cause of death among Americans under 50. Legislation has been passed by every state to increase access to naloxone but dispensing by commun
Externí odkaz:
https://doaj.org/article/bf8387c61dc5400db42b47d17cb2b903
Autor:
Mahip Acharya, Corey J. Hayes, Chenghui Li, Jacob T. Painter, Lindsey Dayer, Bradley C. Martin
Publikováno v:
The Clinical Journal of Pain. 39:107-118
Autor:
Corey J. Hayes, Michael A. Cucciare, Bradley C. Martin, Teresa J. Hudson, Keith Bush, Weihsuan Lo-Ciganic, Hong Yu, Elizabeth Charron, Adam J. Gordon
Publikováno v:
Subst Abus
Medication treatment for opioid use disorder (MOUD) is an effective evidence-based therapy for decreasing opioid-related adverse outcomes. Effective strategies for retaining persons on MOUD, an essential step to improving outcomes, are needed as roug
Autor:
Bradley C. Martin, Corey J. Hayes, Erin E. Krebs, Joshua D. Brown, Teresa J. Hudson, Chenghui Li
Publikováno v:
J Pain
The purpose of this study was to evaluate changes in pain intensity among Veterans transitioning from long-term opioid therapy (LTOT) to either intermittent therapy or discontinuation compared to continued LTOT. Pain intensity was assessed using the
Publikováno v:
Journal of Pain Research
Corey J Hayes,1,2 Laura E Gressler,3 Bo Hu,1,2 Bobby L Jones,4 J Silas Williams,1,2 Bradley C Martin5 1Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, North Little Rock, AR, USA; 2Center of Health Serv
Autor:
Corey J. Hayes, Ruston M. Koonce, Laura Elisabeth Gressler, Bo Hu, James Silas Williams, Bradley C. Martin
Publikováno v:
Pharmacoepidemiol Drug Saf
PURPOSE: We identified associations between membership in seven group-based trajectories based on supply of filled opioid prescriptions and potential opioid-related adverse health events over a 720-day window. METHODS: We identified two veteran cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea59af8c189b197e7d10ef584cbd2db
https://europepmc.org/articles/PMC10052807/
https://europepmc.org/articles/PMC10052807/
Autor:
Nishank Jain, Bradley C. Martin, Junqiang Dai, Milind A. Phadnis, Layth Al-Hindi, Theresa I. Shireman, S. Susan Hedayati, Rafia S. Rasu, Jawahar L. Mehta
Publikováno v:
Kidney360
BACKGROUND: Individuals aged ≥75 years are the fastest-growing population starting dialysis for end-stage kidney disease (ESKD) due to living longer with coronary artery disease. ESKD alone can increase bleeding risk, but P2Y(12) inhibitor (P2Y12-I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45811ea0fd1c5809cf3d196f37dabb9f
https://europepmc.org/articles/PMC9416835/
https://europepmc.org/articles/PMC9416835/